Study identification

EU PAS number

EUPAS21356

Study ID

26587

Official title and acronym

Study of regulatory communication and risk awareness following the Article 31 referral of Combined Hormonal Contraceptives in relation to thromboembolism

DARWIN EU® study

No

Study countries

Denmark
Slovakia
Spain
United Kingdom

Study description

This study uses surveys and questionnaires to study whether women and prescribers consider the risks of venous thromboembolism when making decisions about the use of combined hormonal contraceptives and what sources of information inform their assessments

Study status

Finalised
Research institutions and networks

Institutions

University College London United Kingdom

Networks

Aarhus University Consotrium (ad hoc)

Contact details

Henrik Toft Sørensen

Primary lead investigator

Study timelines

Date when funding contract was signed

Planned:
Actual:

Study start date

Planned:
Actual:

Date of final study report

Planned:
Actual:
Sources of funding
EMA
Regulatory

Was the study required by a regulatory body?

Yes

Is the study required by a Risk Management Plan (RMP)?

Not applicable